PITTSBURGH (February 10, 2014) The University of Pittsburgh's Center for Medical Innovation (CMI) awarded a total of $82,000 to six research groups through its 2013 Round-2 Pilot Funding Program for Early Stage Medical Technology Research and Development. The latest research to receive funding includes projects ranging from a "smart" topical wound gel and CPR system to an infectious disease detection device and a prototype instrument for minimally-invasive brain surgery.
CMI, a University Center housed in Pitt's Swanson School of Engineering, funds applied technology projects that are in the early stages of development, with the goal of ultimately transitioning the work to clinical adoption. Proposals were evaluated on the basis of scientific merit, technical and clinical relevance, potential health care impact and significance, experience of the investigators, and potential in obtaining further financial investment to translate the particular solution to healthcare. Funding ranges from $10,000-$25,000 each.
"CMI serves as a critical "kickstart" for biomedical devices that are ready to move to the next level of R&D, and so we're excited for the potential of these six projects," said Alan D. Hirschman, PhD, CMI Executive Director. "The CMI leadership team was impressed by the quality of these proposals, which represent some of the most intriguing early-stage interdisciplinary research at Pitt and UPMC. "
FOR: CUROSTEM: Cellular Bio-bandage
Award to develop Curostem, a 'smart' topical wound gel, which incorporates biological and pharmacological materials into a bioengineered polymer gel topically applied to non-healing wounds in all clinical care settings.
Donald P. Taylor, PhD, M.B.A.
Department of Bioengineering, Swanson School of Engineering (SSOE)
Austin Nuschke (Student co-PI)
Department of Pathology, UPMC
Alan Wells, MD, D.M.Sc.
|Contact: Paul Kovach|
University of Pittsburgh